QuVa Pharma, Inc. recalls R.E.C.K. (Ropivacaine, Epinephrine, Clonidine, Ketorolac) in Sodium Chloride solution 50 mL in 60 mL Syringe, Compounded
Recalled July 1, 2020 · FDA recall D-1335-2020 · QuVa Pharma
Hazard
Presence of Particulate Matter: Fresenius Kabi recalling vials of Ketorolac · FDA Class III
Units
17,050 syringes
Sold at
Distributed Nationwide in the US.
Description
Presence of Particulate Matter: Fresenius Kabi recalling vials of Ketorolac
Product
R.E.C.K. (Ropivacaine, Epinephrine, Clonidine, Ketorolac) in Sodium Chloride solution 50 mL in 60 mL Syringe, Compounded by QuVa 519 Bloombury, NJ 08804, NDC 70092143350
Manufacturer(s)
QuVa Pharma, Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →